Skip to main content
. 2019 Jul 1;22(7):838–843. doi: 10.1089/jpm.2018.0439

Table 1.

Patient Characteristics

Characteristic All patients
N = 40
Age, mean (SD), years 56 (13)
Male gender, n (%) 20 (50)
Hispanic/white, n (%) 40 (100)
Language, n (%)
 Spanish 28 (70)
 English 12 (30)
Did not complete high school, n (%) 25 (63)
Married/domestic partner, n (%) 16 (40)
Employed, n (%) 2 (5)
Income, n (%)
 Less than $15K 33 (83)
 $15–30K 7 (17)
History of diabetes, n (%) 30 (75)
History of CVD, n (%) 7 (18)
Charlson comorbidity index score, mean standard deviation 7.2 ± 2.7
Laboratory values, mean (SD)
 Creatinine, mg/dL 8.9 (3.7)
 Serum albumin, g/dL 3.7 (0.5)
 Hemoglobin, g/dL 10.4 (1.9)
 Phosphorus, mg/dL 4.8 (1.4)
KDQOL-36 SF, mean (SD)
 Burden of kidney disease 33 (27)
 Symptoms/problems 68 (21)
 SF-12 physical health composite 33 (1)
 SF-23 mental health composite 45 (13)
PHQ-9, median (IQR) 4 (1,10)
PHQ-9 ≥ 10, n (%) 13 (30)
ESAS-r:Renal, mean (SD)
 Symptoms present 6 (3)
 Symptoms moderate/severe 5 (4)
GAD-7, median (IQR) 4 (1, 9)
GAD-7 ≥ 10, n (%) 10 (25)

SD, standard deviation; KDQOL-SF, Kidney Dialysis Quality of Life Short Form; ESAS-r:Renal Modified Edmonton Symptom Assessment Scale; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; IQR, interquartile range; CVD, cardiovascular disease.